Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Moderna, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
793 institutional managers report a position in Moderna, Inc. worth $25.2B between them, filed on form 13F for the quarter ending 2026-06-30. 27 of them hold 80% of it, the largest being FMR LLC at 14.40%.
768 more managers in the register
27 managers hold 80% of the $25.2B institutional base. The other 766 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
MRNA (Moderna, Inc.) has 7 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: CTMX +1.49%, in healthcare.
via Capital World Investors, Baillie Gifford & Co, Norges Bank +2 more · 6.18% of MRNA, 7.92% of NET
via Capital World Investors, Baillie Gifford & Co, Norges Bank +1 more · 6.18% of MRNA, 7.71% of BAP
via Capital World Investors, Baillie Gifford & Co, Qube Research & Technologies Ltd · 6.18% of MRNA, 10.82% of CPA
via Capital World Investors, Baillie Gifford & Co, Norges Bank · 6.18% of MRNA, 5.90% of KNF
via Baillie Gifford & Co, Capital World Investors, Norges Bank +3 more · 5.05% of MRNA, 7.23% of MELI
via Capital World Investors, Baillie Gifford & Co, Norges Bank +1 more · 6.18% of MRNA, 16.73% of RYAAY
Managers holding a meaningful stake in MRNA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.